TODAY'S HEADLINES
Healthcare giant Johnson & Johnson has agreed to pay more than $2.2 billion to settle charges it fraudulently promoted drugs and used kickbacks to spur sales, the U.S. Justice Department announced Monday. » More |
|
The estate of a longtime owner and operator of a Buffalo pharmacy has donated $2 million to a local hospice. According to report by radio station WBFO, the money was received from the estate of William Bender. » More |
ADVERTISEMENT
 The Obesity Epidemic
More than 78 million U.S. adults and 12 million children and adolescents are obese, and those numbers increase every day. Articles, video, whitepapers, and resources to help you adapt your practice to confront the growing epidemic.
|
|
Orally administered chemotherapies have become standards of care with melanoma, non-small cell lung cancer, and some forms of leukemia, with an estimated one third of all new cancer treatments being developed as oral formulations. » More |
|
FDA has approved a new boxed warning for the anti-seizure drug ezogabine (Potiga) because of the potential risk of vision loss, retinal abnormalities, as well as skin, nail, mucous membrane, and sclera discoloration. » More |
Continuing Education
Drug Topics offers the second part of a two-part CPE series, "MTM considerations in osteoporosis care." Earn up to 2 credits by completing this activity. To read and print the October article with TEST QUESTIONS, click here. To proceed to the online exams and earn up to 2 CPE credits, click here to log in.
Announcement: Welcome to the new user registration process. This new process requires all pharmacists and pharmacy technicians to provide
or update their NABP e-Profile ID in order to electronically keep track of CPE credits from ACPE-accredited providers. If you have not done so, you can obtain your NABP e-Profile ID now at www.MyCPEmonitor.net. This profile will enable you to have one login
for all the NABP programs and services you will need throughout your career. |
|
|
Like
Tweet
